title: First vanguard anti-MRSA agent approved.
authors.forename: Jeffrey L
authors.initials: JL
authors.lastname: Fox
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017277:Drug Approval; D004345:Drug Industry; D019317:Evidence-Based Medicine; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D017334:Teicoplanin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000900:Anti-Bacterial Agents; D017334:Teicoplanin; C469289:dalbavancin